Cargando…
Protein Transduction Domain-Mediated Delivery of Recombinant Proteins and In Vitro Transcribed mRNAs for Protein Replacement Therapy of Human Severe Genetic Mitochondrial Disorders: The Case of Sco2 Deficiency
Mitochondrial disorders represent a heterogeneous group of genetic disorders with variations in severity and clinical outcomes, mostly characterized by respiratory chain dysfunction and abnormal mitochondrial function. More specifically, mutations in the human SCO2 gene, encoding the mitochondrial i...
Autores principales: | Miliotou, Androulla N., Foltopoulou, Parthena F., Ingendoh-Tsakmakidis, Alexandra, Tsiftsoglou, Asterios S., Vizirianakis, Ioannis S., Pappas, Ioannis S., Papadopoulou, Lefkothea C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861957/ https://www.ncbi.nlm.nih.gov/pubmed/36678915 http://dx.doi.org/10.3390/pharmaceutics15010286 |
Ejemplares similares
-
Development of a novel PTD-mediated IVT-mRNA delivery platform for potential protein replacement therapy of metabolic/genetic disorders
por: Miliotou, Androulla N., et al.
Publicado: (2021) -
In vivo biodistribution study of TAT-L-Sco2 fusion protein, developed as protein therapeutic for mitochondrial disorders attributed to SCO2 mutations
por: Kaiafas, Georgios C., et al.
Publicado: (2020) -
Recruiting In Vitro Transcribed mRNA against Cancer Immunotherapy: A Contemporary Appraisal of the Current Landscape
por: Miliotou, Androulla N., et al.
Publicado: (2023) -
PTD-mediated delivery of α-globin chain into Κ-562 erythroleukemia cells and α-thalassemic (HBH) patients’ RBCs ex vivo in the frame of Protein Replacement Therapy
por: Miliotou, Androulla N., et al.
Publicado: (2021) -
The Potential Role of Cell Penetrating Peptides in the Intracellular Delivery of Proteins for Therapy of Erythroid Related Disorders
por: Papadopoulou, Lefkothea C., et al.
Publicado: (2013)